Chinese english Germany Japanese Korea

SNDX-5613

SNDX-5613 Struktur
2169919-21-3
CAS-Nr.
2169919-21-3
Englisch Name:
SNDX-5613
Synonyma:
SNDX-5613;Revumenib;SNDX-5613 SNDX5613;acute,Leukemia,inhibit,lymphoblastic,Epigenetic Reader Domain,Inhibitor,AML,Menin,ALL,SNDX 5613,SNDX-5613,SNDX5613,MLL,myeloid;Benzamide, N-ethyl-2-[[4-[7-[[trans-4-[(ethylsulfonyl)amino]cyclohexyl]methyl]-2,7-diazaspiro[3.5]non-2-yl]-5-pyrimidinyl]oxy]-5-fluoro-N-(1-methylethyl)-
CBNumber:
CB47244410
Summenformel:
C32H47FN6O4S
Molgewicht:
630.82
MOL-Datei:
2169919-21-3.mol
Request For Quotation

SNDX-5613 Eigenschaften

Siedepunkt:
739.1±70.0 °C(Predicted)
Dichte
1.28±0.1 g/cm3(Predicted)
Löslichkeit
DMSO:30.0(Max Conc. mg/mL);47.56(Max Conc. mM)
pka
11.10±0.40(Predicted)

Sicherheit

SNDX-5613 Chemische Eigenschaften,Einsatz,Produktion Methoden

SNDX-5613 Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

SNDX-5613 Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 40)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
ATK CHEMICAL COMPANY LIMITED 		+undefined-21-51877795
ivan@atkchemical.com China 32686 60
TargetMol Chemicals Inc. 		+1-781-999-5354 +1-00000000000
 marketing@targetmol.com United States 19892 58
Wuhan Nutra Biotechnology Co.,Ltd 		+8617786394783
 nutrabiotech@outlook.com China 300 58
Zhejiang J&C Biological Technology Co.,Limited 		+1-2135480471 +1-2135480471
 sales@sarms4muscle.com China 10523 58
Nantong HI-FUTURE Biology Co., Ltd. 		+undefined18051384581
 sales@chemhifuture.com China 3136 58
Wuhan Topule Biopharmaceutical Co., Ltd 		+8618327326525
 masar@topule.com China 8474 58
Aladdin Scientific 		+1-833-552-7181
sales@aladdinsci.com United States 57511 58
Shanghai SuperLan Chemcial Technique Centre 021-2022843681 15618226720
 chaolaichem@foxmail.com China 9038 58
SINO High Goal Chemical Technology Co., Ltd. 021-57646680 18306277365
 sunkai@chembiobanksh.com China 2048 55
ShangHai Caerulum Pharma Discovery Co., Ltd. 18149758185
 sales-cpd@caerulumpharma.com China 3421 58
  • SNDX-5613
  • acute,Leukemia,inhibit,lymphoblastic,Epigenetic Reader Domain,Inhibitor,AML,Menin,ALL,SNDX 5613,SNDX-5613,SNDX5613,MLL,myeloid
  • Benzamide, N-ethyl-2-[[4-[7-[[trans-4-[(ethylsulfonyl)amino]cyclohexyl]methyl]-2,7-diazaspiro[3.5]non-2-yl]-5-pyrimidinyl]oxy]-5-fluoro-N-(1-methylethyl)-
  • SNDX-5613 SNDX5613
  • Revumenib
  • 2169919-21-3
Copyright 2019 © ChemicalBook. All rights reserved